Cutler Group LP Red Hill Biopharma Ltd. Put Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q4 2021 Jan 18, 2022	SELL	$2.31 - $5.85 $4,620 - $11,700	-2,000 Reduced 25.97%	5,700 $17,000
Q3 2021 Oct 26, 2021	BUY	$4.55 - $10.36 $35,035 - $79,772	7,700 New	7,700 $16,000
Q2 2021 Jul 19, 2021	SELL	$5.98 - $7.51 $2,392 - $3,004	-400 Closed	0 $0
Q1 2021 Apr 26, 2021	SELL	$6.98 - $11.29 $2,094 - $3,386	-300 Reduced 42.86%	400 $0
Q1 2020 May 07, 2020	BUY	$3.51 - $6.17 $2,106 - $3,702	600 Added 600.0%	700 $2,000
Q3 2019 Oct 28, 2019	BUY	$6.46 - $8.37 $646 - $836	100 New	100 $0

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.